Prime Medicine clears path for two liver programs, gains RMAT for PM359Aug 6Quarterly updatePrime Medicine, Inc.
Prime Medicine registers Phase 1/2 trial of PM577a prime editing therapy for Wilson diseaseAug 5Trial updatePM577APrime Medicine, Inc.